Quarterly report · Q1

Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥9.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥33.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥8.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥2.0bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥2.0bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.7bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.9bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.5bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.5bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥77.1bnat 2023-06-30Cons.Assets
Total assets¥75.6bnat 2023-03-31Cons.Assets
Total assets¥75.0bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥7.5bnat 2023-06-30Cons.Liabilities
Total liabilities¥8.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥69.6bnat 2023-06-30Cons.Net assets
Net assets / equity¥67.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥67.3bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥20.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥23.5bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥34.622023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.492022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.622022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio90.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.8%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-06-30¥327m
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-06-30¥971m
—segment totalrevenue2023-04-01 → 2023-06-30¥9.7bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥9.7bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00970-000LALreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.8bn
jpcrp040300-q1r_E00970-000LALreportable segmentsegment profit2022-04-01 → 2022-06-30¥899m
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-06-30¥227m
—segment totalrevenue2022-04-01 → 2022-06-30¥8.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥8.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 382
ItemContextValueUnit
Noncurrent liabilitiesPrior1YearInstant1709000000JPY
Noncurrent liabilitiesCurrentQuarterInstant2116000000JPY
LiabilitiesPrior1YearInstant8408000000JPY
LiabilitiesCurrentQuarterInstant7511000000JPY
Capital stockPrior1YearInstant3840000000JPY
Capital stockCurrentQuarterInstant3840000000JPY
Capital surplusPrior1YearInstant5301000000JPY
Capital surplusCurrentQuarterInstant5301000000JPY
Retained earningsPrior1YearInstant53975000000JPY
Retained earningsCurrentQuarterInstant55154000000JPY
Treasury stockPrior1YearInstant-2279000000JPY
Treasury stockCurrentQuarterInstant-2279000000JPY
Shareholders equityPrior1YearInstant60837000000JPY
Shareholders equityCurrentQuarterInstant62016000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant3033000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant4057000000JPY
Deferred gains or losses on hedgesPrior1YearInstant-14000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-JPY
Foreign currency translation adjustmentPrior1YearInstant2937000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant3081000000JPY
Remeasurements of defined benefit plansPrior1YearInstant423000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant399000000JPY
Valuation and translation adjustmentsPrior1YearInstant6379000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant7539000000JPY
Net assetsPrior1YearInstant67216000000JPY
Net assetsCurrentQuarterInstant69555000000JPY
Liabilities and net assetsPrior1YearInstant75625000000JPY
Liabilities and net assetsCurrentQuarterInstant77067000000JPY
Net salesPrior1YTDDuration8307000000JPY
Net salesCurrentYTDDuration9661000000JPY
Cost of salesPrior1YTDDuration3622000000JPY
Cost of salesCurrentYTDDuration4477000000JPY
Gross profitPrior1YTDDuration4684000000JPY
Gross profitCurrentYTDDuration5183000000JPY
Personal expenses sgaPrior1YTDDuration680000000JPY
Personal expenses sgaCurrentYTDDuration780000000JPY
Provision for bonuses sgaPrior1YTDDuration89000000JPY
Provision for bonuses sgaCurrentYTDDuration83000000JPY
Retirement benefit expenses sgaPrior1YTDDuration26000000JPY
Retirement benefit expenses sgaCurrentYTDDuration25000000JPY
Research and development expenses sgaPrior1YTDDuration1687000000JPY
Research and development expenses sgaCurrentYTDDuration1738000000JPY
Other sgaPrior1YTDDuration1074000000JPY
Other sgaCurrentYTDDuration1257000000JPY
Selling general and administrative expensesPrior1YTDDuration3558000000JPY
Selling general and administrative expensesCurrentYTDDuration3885000000JPY
Operating incomePrior1YTDDuration1126000000JPY
Operating incomeCurrentYTDDuration1298000000JPY
Interest income noiPrior1YTDDuration5000000JPY
Interest income noiCurrentYTDDuration29000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass